Cargando…
Unleashing the Power of NR4A1 Degradation as a Novel Strategy for Cancer Immunotherapy
An effective cancer therapy requires both killing cancer cells and targeting tumor-promoting pathways or cell populations within the tumor microenvironment (TME). We purposely search for molecules that are critical for multiple tumor-promoting cell types and identified nuclear receptor subfamily 4 g...
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cold Spring Harbor Laboratory
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441411/ https://www.ncbi.nlm.nih.gov/pubmed/37609171 http://dx.doi.org/10.1101/2023.08.09.552650 |